The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioCryst (BCRX – Research Report), Addus Homecare (ADUS – ...
The Hartford Healthcare Fund (I share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more ...
Hims & Hers Health beat fourth-quarter estimates and guided for better-than-expected revenue in the first quarter and 2025. The telehealth provider logged earnings of 11 cents a share on revenue of ...
Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.
Health-care companies rose as traders rotated into defensive sectors.
Shares of Hims & Hers Health (HIMS) sank in after-hours trading after the healthcare company reported earnings for its fourth ...
The Offering was conducted on a firm commitment basis. Craft Capital Management LLC and D. Boral Capital LLC acted as underwriters for the Offering (the "Underwriters”). Dykema Gossett PLLC acted as ...
These two Canadian stocks offer it all – growing industries that remain essential, plus high dividends. So what are you ...
While these stocks are trading cheap, they have significant room for growth, making them solid investments for wealth ...
Looking for the latest stock opportunities in March 2025? We have you covered. Click to read our top stock picks to consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback